"Through-the-strut" re-entry technique: a successful endovascular salvage of iatrogenic subintimal stent deployment in the common iliac artery

Tuan Anh Vo1, , Cong Tien Nguyen1, Thoi Hai Nguyen Nguyen1
1 Thoracic and cardiovascular surgery department, Dong Nai General Hospital

Main Article Content

Abstract

Introduction: Endovascular-first strategies for aortoiliac occlusive disease (AIOD) are standard, yet they carry risks of iatrogenic complications. Subintimal stent deployment is a rare but limb-threatening event that traditionally requires emergency open surgery. This report describes a successful endovascular bailout using a novel through-the-strut re-entry technique.


Case presentation: A 58-year-old male with diabetes and a 40 pack-year smoking history presented with rest pain and cyanosis of the right first toe (Rutherford 4). Imaging confirmed severe right common iliac artery (CIA) stenosis. During intervention, a 0.035” hydrophilic wire inadvertently created a subintimal dissection. A 7 – 57 mm balloon-expandable stent (Besmooth) was deployed within the false lumen, causing acute limb ischemia. The complication was managed by navigating a 5F JR catheter through the misplaced stent's struts to re-access the true lumen. After sequential balloon dilatation through the struts (4F to 7F), an 8 – 100 mm self-expanding Lifestent was deployed to re-line the artery, crushing the initial stent against the wall. Immediate blood flow was restored. The ankle-brachial index improved from 0.4 pre-procedure to 1.1 after intervention. At 6-month follow-up, the patient remained asymptomatic with a patent "stent-in-stent" complex on CTA.


Conclusion: Iatrogenic subintimal stent deployment can be successfully salvaged through the "through-the-strut" technique. This approach avoids the high morbidity of emergency open bypass in high-risk patients and provide an effective endovascular bailout strategy to restore true lumen perfusion and avoid emergency surgical conversion in selected patients..

Article Details

References

1. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007;45 Suppl S:S5-67. doi: 10.1016/j.jvs.2006.12.037
2. Klein AJ, Jaff MR, Gray BH, et al. SCAI expert consensus statement for aorto-iliac arterial intervention appropriate use. Catheter Cardiovasc Interv. 2014;84(4):520-528. doi: 10.1002/ccd.25505
3. Björck M, Koelemay M, Acosta S, et al. Editor's Choice - European Society for Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the Management of Acute Limb Ischaemia. Eur J Vasc Endovasc Surg. 2020;59(2):173-218. doi: 10.1016/j.ejvs.2019.09.006
4. Carlo C, Latz CA, Boitano LT, et al. An Endovascular-First Approach for Aortoiliac Occlusive Disease is Safe. Ann Vasc Surg. 2021;70:62-69. (Ref #41 in ACR document).
5. Klein AJ, Jaff MR, Gray BH, et al. SCAI expert consensus statement for aorto-iliac arterial intervention appropriate use. Catheter Cardiovasc Interv. 2014;84(4):520-528. (Standard reference in SCAI Evidence Tables).
6. Kokkinidis et al. Primary and secondary patency in EIA, CTO, and calcified lesions using SES and BES. Journal of Endovascular Therapy. 2018;25(2):183–191. (SCAI Evidence Table, Page 1).
7. Zander et al. Bifurcated endograft as a minimally invasive alternative to open surgery in high surgical risk patients. J Vasc Interv Radiol. 2011;22:1124–1130. (SCAI Evidence Table, Page 197).
8. Rocha-Neves J, Ferreira A, Sousa J, et al. Endovascular Approach Versus Aortobifemoral Bypass Grafting: Outcomes in Extensive Aortoiliac Occlusive Disease. Vasc Endovascular Surg. 2020;54(2):102-110. (Ref #44 in ACR document).